| ASSET | QUARTER | % RETURN |
|---|---|---|
TG Therapeutics (TGTX) | Q1 2012 | 233.33% |
Patrick Industries (PATK) | Q1 2012 | 194.19% |
Quantum Computing (QUBT) | Q1 2012 | 177.78% |
Caesars Entertainment (CZR) | Q1 2012 | 161.17% |
IES (IESC) | Q1 2012 | 110.96% |
Sarepta Therapeutics (SRPT) | Q1 2012 | 103.97% |
ACADIA Pharmaceuticals (ACAD) | Q1 2012 | 95.45% |
Radian (RDN) | Q1 2012 | 83.66% |
Frontline (FRO) | Q1 2012 | 73.2% |
Civitas Resources (CIVI) | Q1 2012 | 72.86% |
Skyline (SKY) | Q1 2012 | 71.53% |
Capri (CPRI) | Q1 2012 | 70.97% |
Repligen (RGEN) | Q1 2012 | 70.52% |
Skyworks Solutions (SWKS) | Q1 2012 | 63.61% |
Marriot Vacations Worldwide (VAC) | Q1 2012 | 63.38% |
HCI (HCI) | Q1 2012 | 62.6% |
Whirlpool (WHR) | Q1 2012 | 60.05% |
Terex (TEX) | Q1 2012 | 58.12% |
Westlake Chemical (WLK) | Q1 2012 | 57.83% |
Arrowhead Pharmaceuticals (ARWR) | Q1 2012 | 52.27% |
ASGN (ASGN) | Q1 2012 | 51.52% |
Prestige Brand (PBH) | Q1 2012 | 50.69% |
IPG Photonics (IPGP) | Q1 2012 | 48.93% |
Amicus Therapeutics (FOLD) | Q1 2012 | 48.73% |
RadNet (RDNT) | Q1 2012 | 46.54% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
